Appointment booking for Dr. Joel Meshulam, MD is currently not available.Dr. Joel Meshulam, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Joel Meshulam, MD (he/him) is a Internist in Baltimore, MD with over 18 years of experience. What is your opinion of Dr. Joel Meshulam, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Joel Meshulam, MD has received over $3,616 which includes payments from the following companies:
$368.43 from AstraZeneca Pharmaceuticals LP
$350.88 from GlaxoSmithKline, LLC.
$343.47 from LILLY USA, LLC
$245.88 from Novo Nordisk Inc
$205.67 from Allergan Inc.
$188.37 from Purdue Pharma L.P.
$183.39 from Boehringer Ingelheim Pharmaceuticals, Inc.
$180.48 from sanofi-aventis U.S. LLC
$177.12 from AbbVie, Inc.
$173.10 from Kowa Pharmaceuticals America, Inc.
$149.65 from Pfizer Inc.
$148.40 from Janssen Pharmaceuticals, Inc
$143.43 from Takeda Pharmaceuticals America, Inc.
$115.64 from Actavis Pharma Inc
$101.07 from Ironwood Pharmaceuticals, Inc
$100.83 from Eisai Inc.
$68.63 from Daiichi Sankyo Inc.
$58.87 from Amgen Inc.
$57.72 from Mallinckrodt LLC
$47.80 from Arbor Pharmaceuticals, Inc.
Payments received by Dr. Joel Meshulam, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!